Monoclonal antibody 14C5 targets integrin alphavbeta5.
Burvenich I, Schoonooghe S, Vervoort L, Dumolyn C, Coene E, Vanwalleghem L, Van Huysse J, Praet M, Cuvelier C, Mertens N, De Vos F, Slegers G.
Burvenich I, et al.
Mol Cancer Ther. 2008 Dec;7(12):3771-9. doi: 10.1158/1535-7163.MCT-08-0600.
Mol Cancer Ther. 2008.
PMID: 19074852